Redcliffe Lifetech, a Noida, India-based diagnostics company, raised $61m in funding.
The round was led by LeapFrog Investments, with participation from Healthquad, Schroders, LC Nueva, Growth Spark Ventures and existing investors Chiratae Ventures and Alkemi Venture Partners.
The company intends to use the funds to expand its geographic reach across India, with a focus on expanding its Direct to Consumer Diagnostics into tier 2, 3 and 4 cities, scale its platform, and increase its product offerings to radiology, disease data profiling and lifestyle management.
Led by Dheeraj Jain, Founder, Redcliffe delivers diagnostics services in its network of 22 labs across 14 cities, several of which are already NABL accredited. Its omni-channel infrastructure, which combines innovative online channels with a fleet of 400 highly-trained phlebotomists operating in 100+ cities with home sample collection and an off-line network of 500 collection centres, enables the company to offer more than 3,500 different pathology and specialised tests including genetics at affordable prices.
The deal is subject to standard commercial requirements and is expected to be completed within 30 days.
FinSMEs
09/05/2022